Home > Healthcare > Biotechnology > Bioservices > Bio-Decontamination Market
Bio-Decontamination Market size was valued at around USD 229.5 million in 2023 and is anticipated to register a CAGR of 8.5% between 2024 and 2032. Bio-decontamination refers to the process of eliminating or reducing the presence of harmful microorganisms, such as bacteria, viruses, fungi, and spores from surfaces, equipment, or environments.
This procedure is essential in various industries, including healthcare, pharmaceuticals, biotechnology, and food processing companies to prevent the spread of infectious diseases and ensure product safety. Bio-decontamination methods commonly involve the use of chemical agents, such as disinfectants or sterilant, as well as physical methods such as heat or radiation, to achieve effective microbial elimination or reduction. The increasing prevalence of hospital acquired infections (HAIs) is a significant driver for the market.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Bio-Decontamination Market Size in 2023: | USD 229.5 Million |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 8.5% |
2032 Value Projection: | USD 475.5 Million |
Historical Data for: | 2018 – 2023 |
No. of Pages: | 195 |
Tables, Charts & Figures: | 278 |
Segments covered: | Product and Service, Agent Type, Type, End-user, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
For instance, according to data from the World Health Organization (WHO) in 2023, the rate of HAIs was 25% in developing countries, while in developed countries, it ranges from 5% to 15%. Thus, bio-decontaminations play a crucial role in mitigating the spread of infections and ensuring the safety of patients and healthcare workers. Furthermore, market growth is attributed to multiple factors, including the increasing number of surgical procedures, rising growth in pharmaceutical and biotechnology industry, and the escalating trend of outsourcing bio-decontamination services to third-party providers.